
Quanglong N. Truong
Examiner (ID: 17769, Phone: (571)270-0719 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 746 |
| Issued Applications | 510 |
| Pending Applications | 123 |
| Abandoned Applications | 141 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20583286
[patent_doc_number] => 20260068876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-03-12
[patent_title] => COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 19/319209
[patent_app_country] => US
[patent_app_date] => 2025-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19319209
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/319209 | COMPOSITION | Sep 3, 2025 | Pending |
Array
(
[id] => 20817581
[patent_doc_number] => 12673035
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-07
[patent_title] => Solid dosage forms of elafibranor
[patent_app_type] => utility
[patent_app_number] => 19/302463
[patent_app_country] => US
[patent_app_date] => 2025-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11862
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19302463
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/302463 | Solid dosage forms of elafibranor | Aug 17, 2025 | Issued |
Array
(
[id] => 20098975
[patent_doc_number] => 20250228911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-17
[patent_title] => BURDOCK SEED OIL-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 19/169459
[patent_app_country] => US
[patent_app_date] => 2025-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19169459
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/169459 | Burdock seed oil-containing composition and method for producing same | Apr 2, 2025 | Issued |
Array
(
[id] => 20270677
[patent_doc_number] => 12440441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Pharmaceutical solution of amlodipine
[patent_app_type] => utility
[patent_app_number] => 19/013003
[patent_app_country] => US
[patent_app_date] => 2025-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8893
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19013003
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/013003 | Pharmaceutical solution of amlodipine | Jan 7, 2025 | Issued |
Array
(
[id] => 20057123
[patent_doc_number] => 20250195345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => WHIPPED FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/950919
[patent_app_country] => US
[patent_app_date] => 2024-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18950919
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/950919 | WHIPPED FORMULATIONS | Nov 17, 2024 | Pending |
Array
(
[id] => 19798959
[patent_doc_number] => 20250064884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => KOMBUCHA NATURAL HEALTH PROUDCTS
[patent_app_type] => utility
[patent_app_number] => 18/949461
[patent_app_country] => US
[patent_app_date] => 2024-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18949461
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/949461 | KOMBUCHA NATURAL HEALTH PROUDCTS | Nov 14, 2024 | Pending |
Array
(
[id] => 19982664
[patent_doc_number] => 20250120886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => WHIPPED FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/929954
[patent_app_country] => US
[patent_app_date] => 2024-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18929954
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/929954 | WHIPPED FORMULATIONS | Oct 28, 2024 | Pending |
Array
(
[id] => 19768280
[patent_doc_number] => 20250049706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => MAGNETIC FERRITIC NANOCOMPOSITE
[patent_app_type] => utility
[patent_app_number] => 18/926415
[patent_app_country] => US
[patent_app_date] => 2024-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18926415
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/926415 | MAGNETIC FERRITIC NANOCOMPOSITE | Oct 24, 2024 | Pending |
Array
(
[id] => 19752915
[patent_doc_number] => 20250041480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => METHOD AND DEVICE FOR IN VIVO BRONCHUS REGENERATION
[patent_app_type] => utility
[patent_app_number] => 18/921769
[patent_app_country] => US
[patent_app_date] => 2024-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18921769
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/921769 | METHOD AND DEVICE FOR IN VIVO BRONCHUS REGENERATION | Oct 20, 2024 | Pending |
Array
(
[id] => 19752609
[patent_doc_number] => 20250041174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => Skin Barrier Protective Delivery Systems and Methods Thereof
[patent_app_type] => utility
[patent_app_number] => 18/920446
[patent_app_country] => US
[patent_app_date] => 2024-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18920446
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/920446 | Skin Barrier Protective Delivery Systems and Methods Thereof | Oct 17, 2024 | Pending |
Array
(
[id] => 19752674
[patent_doc_number] => 20250041239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/919150
[patent_app_country] => US
[patent_app_date] => 2024-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65895
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919150
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/919150 | ORALLY DISSOLVING ANTIMICROBIAL FILM COMPOSITIONS & METHODS OF THEIR USE | Oct 16, 2024 | Pending |
Array
(
[id] => 19875743
[patent_doc_number] => 20250108000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => IMPLANTABLE NANOCHANNEL DELIVERY DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/915635
[patent_app_country] => US
[patent_app_date] => 2024-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18915635
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/915635 | IMPLANTABLE NANOCHANNEL DELIVERY DEVICES | Oct 14, 2024 | Pending |
Array
(
[id] => 20039384
[patent_doc_number] => 20250177606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => FLOWABLE ACELLULAR TISSUE MATRIX PRODUCTS AND METHODS OF PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/909404
[patent_app_country] => US
[patent_app_date] => 2024-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18909404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/909404 | FLOWABLE ACELLULAR TISSUE MATRIX PRODUCTS AND METHODS OF PRODUCTION | Oct 7, 2024 | Pending |
Array
(
[id] => 19707688
[patent_doc_number] => 20250017830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => SKIN BARRIER PROTECTIVE DELIVERY SYSTEMS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/900108
[patent_app_country] => US
[patent_app_date] => 2024-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900108
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/900108 | SKIN BARRIER PROTECTIVE DELIVERY SYSTEMS AND METHODS THEREOF | Sep 26, 2024 | Pending |
Array
(
[id] => 20185902
[patent_doc_number] => 12397002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => PH stabilized ophthalmic dexamethasone compositions
[patent_app_type] => utility
[patent_app_number] => 18/893806
[patent_app_country] => US
[patent_app_date] => 2024-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8079
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893806
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/893806 | PH stabilized ophthalmic dexamethasone compositions | Sep 22, 2024 | Issued |
Array
(
[id] => 20185901
[patent_doc_number] => 12397001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Treatment of ocular inflammation with ophthalmic compositions
[patent_app_type] => utility
[patent_app_number] => 18/893798
[patent_app_country] => US
[patent_app_date] => 2024-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7935
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893798
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/893798 | Treatment of ocular inflammation with ophthalmic compositions | Sep 22, 2024 | Issued |
Array
(
[id] => 19691217
[patent_doc_number] => 20250009762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => PH STABILIZED OPHTHALMIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/893810
[patent_app_country] => US
[patent_app_date] => 2024-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893810
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/893810 | PH stabilized ophthalmic compositions | Sep 22, 2024 | Issued |
Array
(
[id] => 19691215
[patent_doc_number] => 20250009760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => TREATMENT OF DIABETIC RETINOPATHY WITH OPHTHALMIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/893805
[patent_app_country] => US
[patent_app_date] => 2024-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893805
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/893805 | Treatment of diabetic retinopathy with ophthalmic compositions | Sep 22, 2024 | Issued |
Array
(
[id] => 19691212
[patent_doc_number] => 20250009757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => TREATMENT OF OCULAR INFLAMMATION FOLLOWING OCULAR SURGERY
[patent_app_type] => utility
[patent_app_number] => 18/893790
[patent_app_country] => US
[patent_app_date] => 2024-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893790
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/893790 | Treatment of ocular inflammation following ocular surgery | Sep 22, 2024 | Issued |
Array
(
[id] => 20185900
[patent_doc_number] => 12397000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Stabilized ophthalmic dexamethasone compositions
[patent_app_type] => utility
[patent_app_number] => 18/893796
[patent_app_country] => US
[patent_app_date] => 2024-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8811
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18893796
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/893796 | Stabilized ophthalmic dexamethasone compositions | Sep 22, 2024 | Issued |